Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/1922
Title: Characteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2
Authors: Stepanova, Olena
Kryuchkiov, Y.
Keywords: diabetes mellitus type 2
trimetazidine MR
Issue Date: 2012
Publisher: KNMU
Citation: Stepanova O. Characteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2 / O. Stepanova, Y. Kryuchkiov // 5th International Scientific Interdisciplinary Conference (ISIC) for medical students and young doctors, Kharkiv, April 25–26, 2012 : Abstract book. – Kharkiv, 2012. – P. 77–78.
Abstract: Trimetazidine MR showed high efficiency in the treatment of patients with CDH and diabetes mellitus type 2. The research has shown that adding trimetazidine MR (dosage 70 mg/day) to the basic therapy is advisable for tolerance increase to the physical activity and improvement of the quality of life in patients with CDH and diabetes mellitus type 2.
URI: https://repo.knmu.edu.ua/handle/123456789/1922
Appears in Collections:Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 1

Files in This Item:
File Description SizeFormat 
stepanova1.pdf294,82 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.